Trial Outcomes & Findings for Cognitive Rehabilitation Therapy for Mild Cognitive Impairment (NCT NCT03225482)
NCT ID: NCT03225482
Last Updated: 2025-08-11
Results Overview
Change in composite z score on the following tests: Hopkins Verbal Learning Test-Revised (HVLT-R) Brief Visuospatial Memory Test-Revised (BVMT-R) Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Digit Span WAIS-IV Coding Delis-Kaplan Executive Function System (D-KEFS) Trails, Number and Letter Sequencing D-KEFS Trails, Number-Letter Switching D-KEFS Color-Word Interference Test, Inhibition and Inhibition-Switching A Z score of 0 represents the sample mean. Higher composite Z scores reflect better performance.
COMPLETED
NA
193 participants
assessed at baseline, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.
2025-08-11
Participant Flow
Participants were considered enrolled when they signed the informed consent form. Participants then underwent baseline assessment. Once six participants completed baseline assessments, they were randomized as a group to a condition, revealed to them on the first day of treatment. Some participants exited prior to baseline assessment or after baseline assessment but before randomization or the first day of treatment. Thus, the number initiating treatment differs from the number enrolled.
Participant milestones
| Measure |
ME-CCT Group
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Overall Study
STARTED
|
79
|
66
|
|
Overall Study
COMPLETED
|
76
|
61
|
|
Overall Study
NOT COMPLETED
|
3
|
5
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Cognitive Rehabilitation Therapy for Mild Cognitive Impairment
Baseline characteristics by cohort
| Measure |
ME-CCT
n=84 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=72 Participants
8-week Goal-focused Supportive Contact group
|
Total
n=156 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
71.2 year
STANDARD_DEVIATION 8.2 • n=5 Participants
|
71.8 year
STANDARD_DEVIATION 7.0 • n=7 Participants
|
71.5 year
STANDARD_DEVIATION 7.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
72 Participants
n=5 Participants
|
65 Participants
n=7 Participants
|
137 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
66 Participants
n=5 Participants
|
57 Participants
n=7 Participants
|
123 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
13 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
4 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
10 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
60 Participants
n=5 Participants
|
60 Participants
n=7 Participants
|
120 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
6 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: assessed at baseline, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.Population: 114 participants had useable data at baseline and 21 weeks.
Change in composite z score on the following tests: Hopkins Verbal Learning Test-Revised (HVLT-R) Brief Visuospatial Memory Test-Revised (BVMT-R) Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Digit Span WAIS-IV Coding Delis-Kaplan Executive Function System (D-KEFS) Trails, Number and Letter Sequencing D-KEFS Trails, Number-Letter Switching D-KEFS Color-Word Interference Test, Inhibition and Inhibition-Switching A Z score of 0 represents the sample mean. Higher composite Z scores reflect better performance.
Outcome measures
| Measure |
ME-CCT
n=66 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=48 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Objective Cognitive Performance Composite z Score
|
.24 Z score
Standard Deviation .39
|
.14 Z score
Standard Deviation .35
|
PRIMARY outcome
Timeframe: assessed at baseline, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.Population: 111 participants had useable data at baseline and 21 weeks.
Change in composite z score on the following measures: UCSD Performance-Based Skills Assessment-Brief (UPSA-B) Medication Management Ability Assessment (MMAA) Neuropsychological Assessment Battery Daily Living Memory Neuropsychological Assessment Battery Judgment Neuropsychological Assessment Battery Driving Scenes A Z score of 0 represents the sample mean. Higher Z scores reflect better performance.
Outcome measures
| Measure |
ME-CCT
n=65 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=46 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Functional Capacity Performance Composite z Score
|
.11 z-score
Standard Deviation .41
|
.17 z-score
Standard Deviation .61
|
SECONDARY outcome
Timeframe: assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.Population: 121 participants had useable data at baseline and 21 weeks.
Change in average total score across Applied Cognition Executive Function and Applied Cognition General Concerns scales. The average total score ranges from 8-40, with higher scores reflecting better subjective cognition.
Outcome measures
| Measure |
ME-CCT
n=69 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=52 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Subjective Everyday Functioning Composite Score
|
2.41 score on a scale
Standard Deviation 4.76
|
.64 score on a scale
Standard Deviation 4.46
|
SECONDARY outcome
Timeframe: assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.Population: 122 participants had useable data at baseline and 21 weeks.
Change in total score on the Everyday Cognition Scale. Total scores range from 39-195, with higher scores reflecting worse everyday cognition.
Outcome measures
| Measure |
ME-CCT
n=69 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=53 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Everyday Cognition Scale
|
-.32 score on a scale
Standard Deviation .55
|
-.10 score on a scale
Standard Deviation .41
|
SECONDARY outcome
Timeframe: assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.Population: 120 participants had useable data at baseline and 21 weeks.
Change in total score on the Cognitive Activity Inventory. Scores represent hours per month of cognitive activity and range from 0-730 (the number of hours in a month). Higher scores represent more hours of cognitive activity.
Outcome measures
| Measure |
ME-CCT
n=68 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=52 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Cognitive Activity Inventory
|
24.37 hours
Standard Deviation 245.46
|
-26.80 hours
Standard Deviation 288.83
|
SECONDARY outcome
Timeframe: assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.Population: 116 participants had useable data at baseline and 21 weeks.
Change in total score on the CHAMPS Physical Activity Questionnaire for Older Adults. The score reflects hours of exercise per week and ranges from 0-168 (the number of hours in one week). Higher scores reflect higher levels of exercise.
Outcome measures
| Measure |
ME-CCT
n=64 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=52 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in CHAMPS Physical Activity Questionnaire for Older Adults
|
-2.02 hours
Standard Deviation 9.15
|
1.76 hours
Standard Deviation 9.80
|
SECONDARY outcome
Timeframe: assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.Population: 119 participants had useable data at baseline and 21 weeks.
Change in total score on the Portland Cognitive Strategies Scale. Scores reflect use of cognitive strategies and range from 0-60, with higher scores reflecting greater use of cognitive strategies.
Outcome measures
| Measure |
ME-CCT
n=68 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=51 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Portland Cognitive Strategies Scale
|
4.28 score on a scale
Standard Deviation 8.13
|
1.65 score on a scale
Standard Deviation 7.03
|
SECONDARY outcome
Timeframe: assessed at baseline, 1, 2, 3, 4, 5, 6, 7, 8, 21 weeks; change from baseline to 21 weeks reported.Population: 31 participants had useable data at baseline and 21 weeks. Fitbits were only added at the San Diego site.
Change in total daily step count as measured by Fitbit. Scores could range from 0 steps per day to over 20,000 steps per day. Higher scores reflect more steps per day.
Outcome measures
| Measure |
ME-CCT
n=16 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=15 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Fitbit-measured Physical Activity Level
|
146.62 steps
Standard Deviation 1962.36
|
-867.84 steps
Standard Deviation 1198.58
|
SECONDARY outcome
Timeframe: assessed at baseline, 1, 2, 3, 4, 5, 6, 7, 8, 21 weeks; change from baseline to 21 weeks reported.Population: 25 participants had useable data at baseline and 21 weeks. Fitbits were only used at the San Diego site.
Change in total sleep time in minutes, per 24 hours, as measured by Fitbit. Possible scores range from 0-1440 (the number of minutes in 24 hours). Higher scores reflect more minutes of sleep.
Outcome measures
| Measure |
ME-CCT
n=12 Participants
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=13 Participants
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Change in Fitbit-measured Sleep Time
|
-25.63 minutes
Standard Deviation 90.29
|
11.57 minutes
Standard Deviation 64.73
|
Adverse Events
ME-CCT
Supportive Contact Control Group
Serious adverse events
| Measure |
ME-CCT
n=79 participants at risk
8-week Motivationally Enhanced Compensatory Cognitive Training group
|
Supportive Contact Control Group
n=66 participants at risk
8-week Goal-focused Supportive Contact group
|
|---|---|---|
|
Renal and urinary disorders
Urinary retention
|
0.00%
0/79 • 21-week study
No adverse events linked to study procedures.
|
1.5%
1/66 • Number of events 1 • 21-week study
No adverse events linked to study procedures.
|
|
Cardiac disorders
Slow heartbeat
|
0.00%
0/79 • 21-week study
No adverse events linked to study procedures.
|
1.5%
1/66 • Number of events 1 • 21-week study
No adverse events linked to study procedures.
|
|
Psychiatric disorders
Suicide attempt
|
1.3%
1/79 • Number of events 1 • 21-week study
No adverse events linked to study procedures.
|
0.00%
0/66 • 21-week study
No adverse events linked to study procedures.
|
|
Infections and infestations
Pneumonia
|
1.3%
1/79 • Number of events 1 • 21-week study
No adverse events linked to study procedures.
|
0.00%
0/66 • 21-week study
No adverse events linked to study procedures.
|
|
Respiratory, thoracic and mediastinal disorders
COPD
|
1.3%
1/79 • Number of events 1 • 21-week study
No adverse events linked to study procedures.
|
0.00%
0/66 • 21-week study
No adverse events linked to study procedures.
|
|
Infections and infestations
COVID
|
0.00%
0/79 • 21-week study
No adverse events linked to study procedures.
|
1.5%
1/66 • Number of events 1 • 21-week study
No adverse events linked to study procedures.
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place